These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22787181)

  • 1. Cutaneous graft-versus-host disease after proton-based craniospinal irradiation for recurrent Philadelphia-positive acute lymphoblastic leukaemia.
    Sharp H; Grosshans D; Kadia T; Dabaja BS
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22787181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment.
    Gunther JR; Rahman AR; Dong W; Yehia ZA; Kebriaei P; Rondon G; Pinnix CC; Milgrom SA; Allen PK; Dabaja BS; Smith GL
    Pract Radiat Oncol; 2017; 7(6):e401-e408. PubMed ID: 28666906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
    Milgrom SA; Nieto Y; Pinnix CC; Smith GL; Wogan CF; Rondon G; Medeiros LJ; Kebriaei P; Dabaja BS
    J Med Case Rep; 2016 Jul; 10():209. PubMed ID: 27465468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement.
    Hiniker SM; Agarwal R; Modlin LA; Gray CC; Harris JP; Million L; Kiamanesh EF; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):67-74. PubMed ID: 24725690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of risk factors for acute cutaneous graft-versus-host disease after allogeneic stem cell transplantation.
    Vargas-Díez E; Fernández-Herrera J; Marin A; Cámara R; García-Díez A
    Br J Dermatol; 2003 Jun; 148(6):1129-34. PubMed ID: 12828739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous acute graft-versus-host disease with isomorphic disposition over striae distensae in a 12-year-old girl.
    García-Rodiño S; Sánchez-Aguilar D; Aliste C; Vázquez-Veiga H
    Int J Dermatol; 2017 Feb; 56(2):e37-e38. PubMed ID: 27805255
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life.
    Ziemer M; Thiele JJ; Gruhn B; Elsner P
    J Am Acad Dermatol; 2004 Aug; 51(2):318-9. PubMed ID: 15280858
    [No Abstract]   [Full Text] [Related]  

  • 8. Demodicidosis simulating acute graft-versus-host disease after allogeneic stem cell transplantation in one patient with acute lymphoblastic leukemia.
    Román-Curto C; Meseguer-Yebra C; Cañueto J; Fraile-Alonso C; Santos-Briz A; Vázquez L; Fernández-López E
    Transpl Infect Dis; 2012 Aug; 14(4):387-90. PubMed ID: 22487272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
    Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
    Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of manual lymph drainage plus exercise on range of motion and flexibility in refractory chronic cutaneous graft-versus-host disease: A case report.
    Ozdemir K; Keser I; Yegin ZA; Kaynar LA
    Curr Res Transl Med; 2020 Jan; 68(1):1-4. PubMed ID: 31761680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant.
    Corvò R; Paoli G; Barra S; Bacigalupo A; Van Lint MT; Franzone P; Frassoni F; Scarpati D; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):497-503. PubMed ID: 10078628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.
    Bordigoni P; Esperou H; Souillet G; Pico J; Michel G; Lacour B; Reiffers J; Sadoun A; Rohrlich P; Jouet JP; Milpied N; Lutz P; Plouvier E; Cornu G; Vannier JP; Gandemer V; Rubie H; Gratecos N; Leverger G; Stephan JL; Boutard P; Vernant JP
    Br J Haematol; 1998 Aug; 102(3):656-65. PubMed ID: 9722290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-versus-leukaemia effect in children: chronic GVHD has a significant impact on relapse and survival.
    Gustafsson Jernberg A; Remberger M; Ringdén O; Winiarski J
    Bone Marrow Transplant; 2003 Feb; 31(3):175-81. PubMed ID: 12621478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
    Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers ME; Maris MB; Laport GG; Chauncey TR; Lange T; Langston AA; Storer B; Georges GE
    Haematologica; 2011 Aug; 96(8):1113-20. PubMed ID: 21508120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant.
    Renzi D; Marchesi F; De Angelis G; Elia L; Salvatorelli E; Gumenyuk S; Palombi F; Pisani F; Romano A; Spadea A; Papa E; Canfora M; Arcese W; Mengarelli A;
    Chemotherapy; 2017; 62(1):58-61. PubMed ID: 27618144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The skin manifestations of the graft vs. host reaction].
    Biriukov AV; Baranov AE; Selidovkin GD; Evseeva LV; Getling ZM; Persina IS
    Vestn Dermatol Venerol; 1990; (5):16-9. PubMed ID: 2402935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.
    Kennedy GA; Varelias A; Vuckovic S; Le Texier L; Gartlan KH; Zhang P; Thomas G; Anderson L; Boyle G; Cloonan N; Leach J; Sturgeon E; Avery J; Olver SD; Lor M; Misra AK; Hutchins C; Morton AJ; Durrant ST; Subramoniapillai E; Butler JP; Curley CI; MacDonald KPA; Tey SK; Hill GR
    Lancet Oncol; 2014 Dec; 15(13):1451-1459. PubMed ID: 25456364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis.
    Firoz BF; Lee SJ; Nghiem P; Qureshi AA
    Arch Dermatol; 2006 Feb; 142(2):175-82. PubMed ID: 16490845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer screening for childhood cancer survivors after craniospinal irradiation with protons versus x-rays: a dosimetric analysis and review of the literature.
    Kumar RJ; Zhai H; Both S; Tochner Z; Lustig R; Hill-Kayser C
    J Pediatr Hematol Oncol; 2013 Aug; 35(6):462-7. PubMed ID: 23892352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A confusing case of multiple sclerosis and central nervous system graft versus host disease.
    Yoon BN; Ha CK; Lee KW; Park SH; Sung JJ
    Korean J Intern Med; 2016 Sep; 31(5):995-8. PubMed ID: 26842106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.